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Abstract
Background: Mild cognitive impairment (MCI) was recently described as a heterogeneous group
with a variety of clinical outcomes and high risk to develop Alzheimer's disease (AD). Regional
cerebral blood flow (rCBF) as measured by single photon emission computed tomography (SPECT)
was used to study the heterogeneity of MCI and to look for predictors of future development of
AD.
Methods: rCBF was investigated in 54 MCI subjects using Tc-99m hexamethylpropyleneamine
oxime (HMPAO). An automated analysis software (BRASS) was applied to analyze the relative
blood flow (cerebellar ratios) of 24 cortical regions. After the baseline examination, the subjects
were followed clinically for an average of two years. 17 subjects progressed to Alzheimer's disease
(PMCI) and 37 subjects remained stable (SMCI). The baseline SPECT ratio values were compared
between PMCI and SMCI. Receiver operating characteristic (ROC) analysis was applied for the
discrimination of the two subgroups at baseline.
Results: The conversion rate of MCI to AD was 13.7% per year. PMCI had a significantly decreased
rCBF in the left posterior cingulate cortex, as compared to SMCI. Left posterior cingulate rCBF
ratios were entered into a logistic regression model for ROC curve calculation. The area under the
ROC curve was 74%–76%, which indicates an acceptable discrimination between PMCI and SMCI
at baseline.
Conclusion: A reduced relative blood flow of the posterior cingulate gyrus could be found at least
two years before the patients met the clinical diagnostic criteria of AD.
Background
Mild cognitive impairment (MCI) is an operational diag-
nostic term developed to describe the preclinical stage of
Alzheimer's disease (AD). MCI is a heterogeneous group
containing preclinical stage of dementia [1]. The rate at
which MCI subjects convert to AD each year is ten times
more than the rate for normal subjects [2]. Identification
of progressive mild cognitive impairment (PMCI) versus
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non-progressive mild cognitive impairment subjects (SM-
CI) is currently of great theoretical interest and practical
importance. Early therapeutical interventions are more
likely to be effective and the improvement of clinical out-
come may significantly reduce the heavy economic and
social burden.
The utility of functional imaging techniques, such as sin-
gle photon emission computed tomography (SPECT) and
positron emission computed tomography (PET) for the
study of regional abnormalities in AD has been estab-
lished [3,4]. There is agreement that metabolic reduction
and hypoperfusion in the parietal, temporal cortex and
limbic system are consistent findings in AD that often cor-
relate with cognitive functions [3,4]. However, sensorim-
otor cortex, pons, and cerebellum were found to be
relatively preserved [5,6].
In contrast, functional imaging findings for the preclinical
stage of AD are inconsistent [7,8]. Kennedy et al. showed
that there was decreased metabolism in the tempo-pari-
etal region in patients before they met the clinical criteria
of AD [7]. A marked metabolic reduction in the posterior
cingulate gyrus was reported in the transitional stage of
AD patients by Minoshima et al. [6]. Kogure et al.'s study
used a statistical parametric mapping (SPM) technique for
group comparisons and found a significant bilaterally de-
creased rCBF in the posterior cingulate gyrus and precunei
in MCI subjects, as compared to controls at least two years
before they met the clinical diagnosis of AD [8]. However,
only few studies have looked at the heterogeneity of MCI.
Johnson et al. demonstrated that SPECT was a promising
method for the diagnosis of PMCI, in which the combina-
tion of the cingulate gyrus, hippocampal-amygdaloid
complex and thalamus identified more than 80% of the
subjects who would progress to AD after a 16.7 month fol-
low-up [9].
The present study assessed baseline regional cerebral
blood flow (rCBF), using an automated ROI-based analy-
sis software, in a group of MCI subjects who were fol-
lowed clinically for about two years. Specifically, we
wanted to examine preclinical changes of dementia, and
to assess the clinical prediction of dementia and diagnos-
tic accuracy of SPECT for separating PMCI and SMCI at
baseline.
Methods
Subjects selection
Fifty-four MCI patients were evaluated. The patients were
selected from all individuals consecutively investigated
for suspected dementia at the geriatric clinic, Huddinge
University Hospital. Patients were primarily referred from
General practitioners. The clinic serves the large Stock-
holm area with approximately 2 million inhabitants. All
subjects with a diagnosis of MCI at the initial investiga-
tion were included in the study. Patients with other med-
ical psychiatric diagnosis were excluded. No subject
received either psychotropic medication or an acetylcho-
linesterase inhibitor likely to influence the results of
SPECT scanning.
All subjects underwent general medical, neurological, psy-
chiatric and neuropsychological evaluation, as well as
neuroimaging diagnostic procedures (SPECT and MRI) at
the initial investigation. The subjects were clinically fol-
lowed for 28.9  16.3 months on average. After the fol-
low-up period, 17 MCI subjects have progressed to AD.
These MCI subjects were defined as PMCI. 37 remained
MCI and did not fulfill the criteria of dementia during the
observation time. These MCI subjects were defined as SM-
CI. The baseline PMCI and SMCI did not differ with re-
spect to age (PMCI (years): 63.6  7.3, SMCI (years): 60.3
 8.5), gender (PMCI (f/m): 9/8, SMCI (f/m): 24/13), fol-
low-up time (PMCI (months) 26.6  19.0, SMCI
(months) 29.7  16.6) and MMSE (PMCI: 26.2  2.0, SM-
CI: 27.0  2.3).
Diagnosis
Subjects who were diagnosed as MCI did not fulfill the di-
agnostic criteria for dementia according to DSM-IV criteria
and did not have evidence of impairment in social or oc-
cupational functioning, but performed at least 1.5 SD be-
low average for their age on at least one
neuropsychological test [10]. Progressive mild cognitive
impairment (PMCI) referred to the MCI subjects who con-
verted to Alzheimer's disease according to the DSM-IV cri-
teria during the follow up and stable mild cognitive
impairment (SMCI) was defined as the subjects who still
did not fulfill the criteria for dementia according to DSM-
IV during the observation time.
Neuropsychological tests
All subjects were tested by experienced psychologist with
five subtests (Information, Digit Span, Similarities, Block
Design and Digit Symbol) from the Wechsler Adult Intel-
ligence Scale-Revised (WAIS-R), Trail Making Test A and
B, free and recognition words from the Stockholm Geriat-
ric Research Center (SGRC) [11,12]. The general level of
cognition was assessed by the Mini-Mental State Examina-
tion (MMSE) [13].
Single photon emission computed tomography (SPECT)
Each subject was injected with 1000 Mbq Tc-99m-HM-
PAO (Ceretec, Amersham Ltd) in a quiet surrounding
with eyes closed. Acquisition started 30 minutes after in-
jection. Data were collected in 64 projections evenly
spread through 360 degrees with a single headed rotating
gamma camera (Siemens Diacam) with a total acquisition
time of 32 minutes. Tomographic slices were reconstruct-BMC Neurology 2002, 2 http://www.biomedcentral.com/1471-2377/2/9
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ed using an iterative algorithm (Hosem, Nuclear Diagnos-
tics AB, Sweden) with Chang attenuation correction
(Attenuation coefficient: 0.12 cm-1). Data were formatted
as a 3D dataset with 64  64  64 cubic voxels with 3.5
mm sides. The resolution in a tomographic slice was
measured to be 10.2 mm (FWHM). The reconstructed
data sets were post-filtered with a Butterworth filter, cutoff
0.7 cm-1.
SPECT registration and quantification
Image registration and quantification were performed
with the BRASS software developed by Nuclear Diagnos-
tics (London, England and Stockholm, Sweden) [14]. The
patient datasets were iteratively registered using 9 param-
eter linear registration to a normal template using normal-
ized mutual information as similarity function. The
software uses a map of 46 volumes-of-interest (VOIs) that
encompass the entire brain [15]. The subjects were nor-
malized according to cerebellar cortex. Mean image of
PMCI and SMCI and the region map were obtained (fig-
ure 1).
The quantification evaluations were performed in 28 cor-
tical regions, since they are the most interesting regions in
AD. The region selected were bilateral sensorimotor, oc-
cipital, parietal, anterior and posterior dorsal frontal, an-
terior and posterior orbital frontal, parieto-temporal,
medial, lateral and posterior temporal lobe, temporal
pole as well as bilateral anterior and posterior cingulate
cortex. The relative regional cerebral blood flow (rCBF) in
the selected regions were calculated as cerebellar ratios.
(Mean value of region/mean value of bilateral cerebellar
cortex.)
Statistics
The baseline VOI results of PMCI and SMCI subjects were
compared using t-test, p < 0.05 was considered to the sig-
nificant level, uncorrected for multiple comparisons, be-
cause of the relative small sample size. The VOIs with
significantly different rCBF between groups were entered
into a logistic model. Receiver operating characteristic
(ROC) analysis was applied for the discrimination be-
tween PMCI and SMCI.
Results
Conversion rate
The conversion rate of MCI to AD was 13.7% per year.
Brain perfusion of PMCI and SMCI
The mean and standard deviation of each relative rCBF
value was shown in Table 1. The box-and-whisker plots of
Left Posterior Cingulate ratio value were shown in figure
2. There was one outlier in SMCI group. T-test was per-
formed within the whole group (W) and after excluding
the outlier (O), separately. PMCI group had a significantly
decreased rCBF in the left posterior cingulate cortex (0.84
 0.07) compared to SMCI (W: 0.91  0.11, t = -2.3529, p
= 0.0224, O: 0.92  0.09, t = -3.2602, p = 0.0020). The
blood flow of the left parieto-temporal lobe had a tenden-
cy to decrease in PMCI (0.88  0.07) compared to SMCI
(W: 0.91  0.05, t = -1.8326, p = 0.0726, O: 0.91  0.05, t
= -1.9911, p = 0.0518).
Logistic regression
The rCBF of left posterior cingulate cortex was entered
into a logistic regression model for the differential diagno-
sis between PMCI and SMCI at baseline within the whole
group (Estimate: -7.17 (-13.89, -0.45), Standard Error
3.43, p = 0.037). ROC analysis was performed with 74%
Figure 1
Regional cerebral blood flow measured with SPECT. a) Mean image of progressive mild cognitive impairment (PMCI). b) Mean
image of stable mild cognitive impairment (SMCI). c) Region map with marked posterior cingulate.
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of the area under the curve. An alternative logistic regres-
sion was performed after we excluded the outlier (Esti-
mate: -12.41 (-21.10, -3.73), Standard Error 4.43, p =
0.005) and the area under the ROC curve was 76%.
Discussion
The present study showed that the conversion rate of MCI
to AD was 13.7% per year, which is comparable with oth-
er cohorts of MCI-patients [2]. Using a recently developed
automated analysis program for rCBF analysis in individ-
ual patients, we found posterior cingulate hypoperfusion
to be the earliest deficit in the transitional stage of AD. A
logistic regression applied for the ROC curve calculation
gave an area under the curve of 74%–76% indicating an
acceptable discrimination of the posterior cingulate cortex
between PMCI and SMCI at baseline.
It was reported in Fox et al's study, using compression
mapping of serial magnetic resonance images, that genet-
ically at risks subjects had posterior cingulate atrophy
years before the onset of dementia [16]. Our SPECT study
was not corrected by MRI. The results could be influenced
by partial volume effect. However, several studies found
that posterior cingulate had reduced metabolism in pre-
clinical dementia, even after the correction of atrophy
[17]. MRI will be performed in our following SPECT
study. For the clinical purpose, the current findings might
be valuable for the prediction of dementia in the hetero-
geneous group of subjects presenting with MCI.
Posterior cingulate cortex was found to participate in cog-
nitive functions such as memory and spatial orientation
[18]. The associations of the posterior cingulate cortex
with medial temporal lobe structures have been demon-
strated in previous studies. This might imply a major role
in memory-related functions of the cingulate cortex. Area
23a and 29/30 of posterior cingulate afferents terminate
in the entorhinal cortex, subiculum has projections to
Figure 2
Box-and-whisker plots of relative regional blood flow in Left Posterior Cingulate. PMCI: progressive mild cognitive impairment.
SMCI: stable mild cognitive impairment.
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area 29/30 and parahippocampus also have wide associa-
tions with the posterior cingulate region [19,20]. Several
investigators showed that the posterior cingulate cortex
contributes to the spatial orientation and spatial working
memory which might rest on the association of parietal
area 7 and parahippocampal gyrus with the spatially selec-
tive firing in layer II of entorhinal cortex [18].
Preclinical AD has been reported having the neuropatho-
logical features of mild AD, including neurofibrillary tan-
gles and neuritic plagues in the medial temporal lobe
[21]. Some studies demonstrated that the initial neuronal
lesions develop in the entorhinal cortex [22]. Gomez-Isla
et al. reported that the predromal phase of AD patients
had a 60% of neuron loss in layer II of the entorhinal cor-
tex and 40% loss in layer IV, as compared to controls [23].
However, no pathological changes have been reported in
the posterior cingulate. Based on the above findings, we
hypothesize that in the preclinical stage of AD, isolation
of the posterior cingulate cortex from the input and out-
put of the medial temporal lobe structures is probably an
important mechanism for the deficits of cognitive func-
tion seen in PMCI subjects. Such cortico-cortical discon-
nection might subsequently result in the decreased rCBF
found in the posterior cingulate cortex. It was also report-
ed that the antero-dorsal nucleus of the thalamus had
pathological changes in preclinical AD [22]. A study of
rhesus monkey showed that the antero-dorsal nucleus as-
sociates with area 29 of the posterior cingulate gyrus [24].
According to the disconnection hypothesis, a lesion of the
antero-dorsal nucleus in transitional AD might also con-
tribute to the subsequent hypoperfusion showed in the
posterior cingulate cortex.
A metabolic reduction of the posterior cingulate was also
found in lewy body disease, indicating that the involve-
ment of the posterior cingulate might be a common
pathophysiological process in neurodegenerative disease
[25]. In addition, our study showed that the parieto-tem-
poral association cortex had a relatively mild hypoper-
fusion in PMCI at baseline. However, previous studies
have indicated that hypoperfusion of the parietal-tempo-
ral cortex was a typical and consistent finding in AD,
which suggests that the parieto-temporal association cor-
tex might be only slightly affected at the preclinical stage
of dementia, but significantly develops as the disease
spreads [8].
Conclusion
Topographical analysis of rCBF in preclinical AD using
SPECT and an automated VOI-based analysis could show
a reduced relative blood flow in the posterior cingulate
cortex at least two years before the subjects with MCI met
the clinical diagnostic criteria of AD. Cingulate hypoper-
fusion is a promising marker for the early detection of AD
in the heterogeneous group of subjects presenting with
mild cognitive impairment.
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Table 1: Means and standard deviations of relative blood flow in 
PMCI and SMCI
Regions Mean (SD)
PMCI SMCI
L sensorimotor 0.90 (0.05) 0.91 (0.05)
R sensorimotor 0.89 (0.04) 0.90 (0.05)
L occipital lobe 0.90 (0.06) 0.92 (0.05)
R occipital lobe 0.89 (0.06) 0.91 (0.05)
L superior parietal lobe 0.87 (0.06) 0.90 (0.06)
R superior parietal lobe 0.87(0.06) 0.89 (0.07)
L anterior dorsal frontal lobe 0.84 (0.04) 0.83 (0.06)
R anterior dorsal frontal lobe 0.85 (0.04) 0.85 (0.07)
L posterior dorsal frontal lobe 0.89 (0.04) 0.89 (0.06)
R posterior dorsal frontal lobe 0.90 (0.04) 0.90 (0.06)
L anterior orbital frontal lobe 0.84 (0.04) 0.84 (0.06)
R anterior orbital frontal lobe 0.85 (0.05) 0.84 (0.07)
L posterior orbital frontal lobe 0.88 (0.04) 0.87 (0.06)
R posterior orbital frontal lobe 0.86 (0.05) 0.86 (0.06)
L parieto-temporal lobe 0.88 (0.07) 0.91 (0.05)
R parieto-temporal lobe 0.89 (0.06) 0.91 (0.06)
L medial temporal lobe 0.82 (0.05) 0.83 (0.07)
R medial temporal lobe 0.82 (0.04) 0.81 (0.06)
L lateral temporal lobe 0.91 (0.06) 0.91 (0.07)
R lateral temporal lobe 0.90 (0.05) 0.90 (0.06)
L posterior temporal lobe 0.94 (0.06) 0.95 (0.06)
R posterior temporal lobe 0.93 (0.06) 0.94 (0.06)
L temporal pole 0.78 (0.06) 0.80 (0.07)
R temporal pole 0.78 (0.05) 0.78 (0.06)
L anterior cingulate cortex 0.88 (0.06) 0.89 (0.08)
R anterior cingulate cortex 0.88 (0.06) 0.89 (0.08)
L posterior cingulate cortex 0.84 (0.07) 0.91 (0.11)
R posterior cingulate cortex 0.80 (0.08) 0.85 (0.129
L: left, R: rightBMC Neurology 2002, 2 http://www.biomedcentral.com/1471-2377/2/9
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